Cost-effectiveness of community-based distribution of intermittent preventive treatment of malaria in pregnancy in Madagascar, Mozambique, Nigeria, and the Democratic Republic of Congo
Introduction Malaria in pregnancy is a major driver of maternal and infant mortality in sub-Saharan Africa. The WHO recommends the administration of intermittent preventive treatment with sulfadoxine pyrimethamine (IPTp-SP) at antenatal care (ANC) visits. Despite being a highly cost-effective strate...
| Published in: | BMJ Global Health |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-07-01
|
| Online Access: | https://gh.bmj.com/content/8/7/e010238.full |
| _version_ | 1851912064852819968 |
|---|---|
| author | Charfudin Sacoor Martin Meremikwu Laia Cirera Clara Pons-Duran Máximo Ramírez Elaine Roman Franco Pagnoni Clara Menendez Raquel González Christina Maly Elisa Sicuri Dachi Arikpo Manu F Manun’Ebo Antía Figueroa-Romero Louise Ranaivo Francesco Ramponi |
| author_facet | Charfudin Sacoor Martin Meremikwu Laia Cirera Clara Pons-Duran Máximo Ramírez Elaine Roman Franco Pagnoni Clara Menendez Raquel González Christina Maly Elisa Sicuri Dachi Arikpo Manu F Manun’Ebo Antía Figueroa-Romero Louise Ranaivo Francesco Ramponi |
| author_sort | Charfudin Sacoor |
| collection | DOAJ |
| container_title | BMJ Global Health |
| description | Introduction Malaria in pregnancy is a major driver of maternal and infant mortality in sub-Saharan Africa. The WHO recommends the administration of intermittent preventive treatment with sulfadoxine pyrimethamine (IPTp-SP) at antenatal care (ANC) visits. Despite being a highly cost-effective strategy, IPTp-SP coverage and uptake remains low. A pilot project was conducted to assess the cost-effectiveness (CE) of community-based delivery of IPTp (C-IPTp) in addition to ANC delivery to increase IPTp uptake in the Democratic Republic of Congo (DRC), Madagascar (MDG), Mozambique (MOZ) and Nigeria (NGA).Methods Costs and CE estimates of C-IPTp were calculated according to two scenarios: (1) costs in ‘programmatic mode’ (ie, costs if C-IPTp was to be implemented by national health systems) and (2) costs from the pilot project. The effectiveness of C-IPTp was obtained through estimates of the averted disability-adjusted life-years (DALYs) associated with maternal clinical malaria and anaemia, low birth weight and neonatal mortality.Results Net incremental costs of C-IPTp ranged between US$6138–US$47 177 (DRC), US$5552–US$31 552 (MDG), US$10 202–US$53 221 (MOZ) and US$667–US$28 645 (NGA) per 1000 pregnant women, under scenarios (1) and (2), respectively. Incremental cost-effectiveness ratios (ICERs) ranged between US$15–US$119 in DRC, US$9–US$53 in MDG, US$104–US$543 in MOZ and US$2–US$66 in NGA per DALY averted, under scenarios (1) and (2), respectively. ICERs fall below the WHO recommended CE threshold based on the gross domestic product per capita.Conclusion Findings suggest that C-IPTp is a highly cost-effective intervention. Results can inform policy decisions on adopting and optimising effective interventions for preventing malaria in pregnancy. |
| format | Article |
| id | doaj-art-cc2848cd2c2f4e69afabbe83a72f3ca1 |
| institution | Directory of Open Access Journals |
| issn | 2059-7908 |
| language | English |
| publishDate | 2023-07-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| spelling | doaj-art-cc2848cd2c2f4e69afabbe83a72f3ca12025-08-19T22:01:33ZengBMJ Publishing GroupBMJ Global Health2059-79082023-07-018710.1136/bmjgh-2022-010238Cost-effectiveness of community-based distribution of intermittent preventive treatment of malaria in pregnancy in Madagascar, Mozambique, Nigeria, and the Democratic Republic of CongoCharfudin Sacoor0Martin Meremikwu1Laia Cirera2Clara Pons-Duran3Máximo Ramírez4Elaine Roman5Franco Pagnoni6Clara Menendez7Raquel González8Christina Maly9Elisa Sicuri10Dachi Arikpo11Manu F Manun’Ebo12Antía Figueroa-Romero13Louise Ranaivo14Francesco Ramponi15Manhiça Health Research Center, Manhiça, MozambiqueCross River Health and Demographic Surveillance System, University of Calabar, Calabar, NigeriaMaternal, Child and Reproductive Health Initiative, Barcelona Institute for Global Health, Barcelona, SpainMaternal, Child and Reproductive Health Initiative, Barcelona Institute for Global Health, Barcelona, SpainMaternal, Child and Reproductive Health Initiative, Barcelona Institute for Global Health, Barcelona, SpainJhpiego, Johns Hopkins University Affiliate, Baltimore, Maryland, USAMaternal, Child and Reproductive Health Initiative, Barcelona Institute for Global Health, Barcelona, SpainManhiça Health Research Center, Manhiça, MozambiqueMaternal, Child and Reproductive Health Initiative, Barcelona Institute for Global Health, Barcelona, SpainJhpiego, Johns Hopkins University Affiliate, Baltimore, Maryland, USAMaternal, Child and Reproductive Health Initiative, Barcelona Institute for Global Health, Barcelona, SpainCross River Health and Demographic Surveillance System, University of Calabar, Calabar, NigeriaBureau d’Étude et de Gestion de l’Information Statistique (BEGIS), Kinshasa, Congo (the Democratic Republic of the)Maternal, Child and Reproductive Health Initiative, Barcelona Institute for Global Health, Barcelona, SpainMalagasy Associates for Numerical Information and Statistical Analysis (MANISA), Antananarivo, MadagascarMaternal, Child and Reproductive Health Initiative, Barcelona Institute for Global Health, Barcelona, SpainIntroduction Malaria in pregnancy is a major driver of maternal and infant mortality in sub-Saharan Africa. The WHO recommends the administration of intermittent preventive treatment with sulfadoxine pyrimethamine (IPTp-SP) at antenatal care (ANC) visits. Despite being a highly cost-effective strategy, IPTp-SP coverage and uptake remains low. A pilot project was conducted to assess the cost-effectiveness (CE) of community-based delivery of IPTp (C-IPTp) in addition to ANC delivery to increase IPTp uptake in the Democratic Republic of Congo (DRC), Madagascar (MDG), Mozambique (MOZ) and Nigeria (NGA).Methods Costs and CE estimates of C-IPTp were calculated according to two scenarios: (1) costs in ‘programmatic mode’ (ie, costs if C-IPTp was to be implemented by national health systems) and (2) costs from the pilot project. The effectiveness of C-IPTp was obtained through estimates of the averted disability-adjusted life-years (DALYs) associated with maternal clinical malaria and anaemia, low birth weight and neonatal mortality.Results Net incremental costs of C-IPTp ranged between US$6138–US$47 177 (DRC), US$5552–US$31 552 (MDG), US$10 202–US$53 221 (MOZ) and US$667–US$28 645 (NGA) per 1000 pregnant women, under scenarios (1) and (2), respectively. Incremental cost-effectiveness ratios (ICERs) ranged between US$15–US$119 in DRC, US$9–US$53 in MDG, US$104–US$543 in MOZ and US$2–US$66 in NGA per DALY averted, under scenarios (1) and (2), respectively. ICERs fall below the WHO recommended CE threshold based on the gross domestic product per capita.Conclusion Findings suggest that C-IPTp is a highly cost-effective intervention. Results can inform policy decisions on adopting and optimising effective interventions for preventing malaria in pregnancy.https://gh.bmj.com/content/8/7/e010238.full |
| spellingShingle | Charfudin Sacoor Martin Meremikwu Laia Cirera Clara Pons-Duran Máximo Ramírez Elaine Roman Franco Pagnoni Clara Menendez Raquel González Christina Maly Elisa Sicuri Dachi Arikpo Manu F Manun’Ebo Antía Figueroa-Romero Louise Ranaivo Francesco Ramponi Cost-effectiveness of community-based distribution of intermittent preventive treatment of malaria in pregnancy in Madagascar, Mozambique, Nigeria, and the Democratic Republic of Congo |
| title | Cost-effectiveness of community-based distribution of intermittent preventive treatment of malaria in pregnancy in Madagascar, Mozambique, Nigeria, and the Democratic Republic of Congo |
| title_full | Cost-effectiveness of community-based distribution of intermittent preventive treatment of malaria in pregnancy in Madagascar, Mozambique, Nigeria, and the Democratic Republic of Congo |
| title_fullStr | Cost-effectiveness of community-based distribution of intermittent preventive treatment of malaria in pregnancy in Madagascar, Mozambique, Nigeria, and the Democratic Republic of Congo |
| title_full_unstemmed | Cost-effectiveness of community-based distribution of intermittent preventive treatment of malaria in pregnancy in Madagascar, Mozambique, Nigeria, and the Democratic Republic of Congo |
| title_short | Cost-effectiveness of community-based distribution of intermittent preventive treatment of malaria in pregnancy in Madagascar, Mozambique, Nigeria, and the Democratic Republic of Congo |
| title_sort | cost effectiveness of community based distribution of intermittent preventive treatment of malaria in pregnancy in madagascar mozambique nigeria and the democratic republic of congo |
| url | https://gh.bmj.com/content/8/7/e010238.full |
| work_keys_str_mv | AT charfudinsacoor costeffectivenessofcommunitybaseddistributionofintermittentpreventivetreatmentofmalariainpregnancyinmadagascarmozambiquenigeriaandthedemocraticrepublicofcongo AT martinmeremikwu costeffectivenessofcommunitybaseddistributionofintermittentpreventivetreatmentofmalariainpregnancyinmadagascarmozambiquenigeriaandthedemocraticrepublicofcongo AT laiacirera costeffectivenessofcommunitybaseddistributionofintermittentpreventivetreatmentofmalariainpregnancyinmadagascarmozambiquenigeriaandthedemocraticrepublicofcongo AT claraponsduran costeffectivenessofcommunitybaseddistributionofintermittentpreventivetreatmentofmalariainpregnancyinmadagascarmozambiquenigeriaandthedemocraticrepublicofcongo AT maximoramirez costeffectivenessofcommunitybaseddistributionofintermittentpreventivetreatmentofmalariainpregnancyinmadagascarmozambiquenigeriaandthedemocraticrepublicofcongo AT elaineroman costeffectivenessofcommunitybaseddistributionofintermittentpreventivetreatmentofmalariainpregnancyinmadagascarmozambiquenigeriaandthedemocraticrepublicofcongo AT francopagnoni costeffectivenessofcommunitybaseddistributionofintermittentpreventivetreatmentofmalariainpregnancyinmadagascarmozambiquenigeriaandthedemocraticrepublicofcongo AT claramenendez costeffectivenessofcommunitybaseddistributionofintermittentpreventivetreatmentofmalariainpregnancyinmadagascarmozambiquenigeriaandthedemocraticrepublicofcongo AT raquelgonzalez costeffectivenessofcommunitybaseddistributionofintermittentpreventivetreatmentofmalariainpregnancyinmadagascarmozambiquenigeriaandthedemocraticrepublicofcongo AT christinamaly costeffectivenessofcommunitybaseddistributionofintermittentpreventivetreatmentofmalariainpregnancyinmadagascarmozambiquenigeriaandthedemocraticrepublicofcongo AT elisasicuri costeffectivenessofcommunitybaseddistributionofintermittentpreventivetreatmentofmalariainpregnancyinmadagascarmozambiquenigeriaandthedemocraticrepublicofcongo AT dachiarikpo costeffectivenessofcommunitybaseddistributionofintermittentpreventivetreatmentofmalariainpregnancyinmadagascarmozambiquenigeriaandthedemocraticrepublicofcongo AT manufmanunebo costeffectivenessofcommunitybaseddistributionofintermittentpreventivetreatmentofmalariainpregnancyinmadagascarmozambiquenigeriaandthedemocraticrepublicofcongo AT antiafigueroaromero costeffectivenessofcommunitybaseddistributionofintermittentpreventivetreatmentofmalariainpregnancyinmadagascarmozambiquenigeriaandthedemocraticrepublicofcongo AT louiseranaivo costeffectivenessofcommunitybaseddistributionofintermittentpreventivetreatmentofmalariainpregnancyinmadagascarmozambiquenigeriaandthedemocraticrepublicofcongo AT francescoramponi costeffectivenessofcommunitybaseddistributionofintermittentpreventivetreatmentofmalariainpregnancyinmadagascarmozambiquenigeriaandthedemocraticrepublicofcongo |
